Fatigue in pediatric patients with familial Mediterranean fever

Semanur Özdel1, Z Birsin Özçakar1, Nilgün Cakar1

  • 1a Department of Pediatrics, Division of Pediatric Rheumatology , Ankara University School of Medicine , Ankara , Turkey.

Modern Rheumatology
|January 12, 2018
PubMed

Insights

Fatigue is a common issue for patients with Familial Mediterranean Fever (FMF), often overlooked. This study found FMF patients experience significant fatigue, similar to other chronic rheumatic diseases.

Area of Science:

  • Rheumatology
  • Pediatric Rheumatology
  • Internal Medicine

Background:

  • Familial Mediterranean Fever (FMF) presents with recurrent fever and serositis.
  • Fatigue is prevalent in pediatric rheumatic diseases but understudied in FMF.
  • Systematic evaluation of fatigue in FMF patients is lacking.

Purpose of the Study:

  • To assess fatigue levels in adolescent and young adult FMF patients.
  • To identify factors associated with fatigue in FMF.
  • To compare fatigue in FMF patients with other chronic rheumatic diseases and healthy controls.

Main Methods:

  • A cohort of 111 FMF patients (aged 10-21) completed the Checklist Individual Strength-20 (CIS-20) fatigue questionnaire.
  • Control groups included 54 patients with other chronic rheumatic diseases and 79 healthy children.
  • Statistical analysis compared fatigue scores between groups and explored associated factors.

Main Results:

  • FMF patients reported fatigue levels comparable to those with other chronic rheumatic diseases.
  • Both FMF and other chronic rheumatic disease groups exhibited significantly higher fatigue scores than healthy controls.
  • FMF patients with musculoskeletal complaints reported more severe subjective fatigue.

Conclusions:

  • Fatigue is a frequent and often unrecognized symptom in FMF patients.
  • FMF may present as a chronic condition with persistent symptoms between acute attacks.
  • Addressing fatigue is crucial for comprehensive FMF management.
Abstract

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
281
Protein Families02:47

Protein Families

Protein families are groups of homologous proteins; that is, they have similarities in amino acid sequences and three-dimensional structures. Protein families usually occur because of gene duplication, where an additional copy of a gene is inserted into the genome of an organism.   Mutations that change the amino acids but still allow the protein to be properly synthesized, will lead to new protein family members.   If these new proteins contain similar amino acids in key...
17.2K
Gene Families01:57

Gene Families

Gene families consist of groups of genes proposed to have originated from a common ancestor. Typically these arise through events in which a gene or genes are mistakenly duplicated during cell division. Unlike their parent genes (which are subject to selection pressure to maintain function), these gene copies do not need to preserve their sequences and may evolve at a relatively faster rate.
Occasionally these regions can be adapted to take on new roles within the organism, becoming novel genes...
10.0K
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
334
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
256
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
318